Dual Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for Glaucoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Dual Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for Glaucoma	eye disorder, glaucoma, ocular hypertension	Active, not recruiting	Phase 2	2025-11-04		NCT04577300

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Stanford University	620

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Byers Eye Institute at Stanford University	Palo Alto	United States	11

Clinical trials